Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian G Baker

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Handbook of Experimental Pharmacology|September 14, 2023
Asthma and COPD: A Focus on β-Agonists - Past, Present and FutureJillian G Baker, Dominick E Shaw
British Journal of Pharmacology|April 25, 2003
The ups and downs of Gs- to Gi-protein switchingStephen J Hill, Jillian G Baker
The Journal of Pharmacology and Experimental Therapeutics|October 5, 2006
A comparison of the antagonist affinities for the Gi- and Gs-coupled states of the human adenosine A1-receptorJillian G Baker, Stephen J Hill
Handbook of Experimental Pharmacology|June 26, 2024
Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and AssaysJillian G Baker, Roger J Summers
Pharmacology Research & Perspectives|September 1, 2025
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β<sub>2</sub>-Agonists Used for Asthma and COPDRichard G W Proudman, Jillian G Baker
Pharmacology Research & Perspectives|August 6, 2021
The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptorsRichard G W Proudman, Jillian G Baker
European Journal of Cancer (Oxford, England : 1990)|June 8, 2021
Response to the letter Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patientsEdoardo Botteri, Jillian G Baker, Erica K Sloan
Trends in Pharmacological Sciences|March 25, 2011
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signallingJillian G Baker, Stephen J Hill, Roger J Summers
Pharmacology Research & Perspectives|September 14, 2022
The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptorsRichard G W Proudman, Juliana Akinaga, Jillian G Baker
Molecular Pharmacology|December 3, 2003
Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signalingJillian G Baker, Ian P Hall, Stephen J Hill
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Handbook of Experimental Pharmacology|September 14, 2023
Asthma and COPD: A Focus on β-Agonists - Past, Present and FutureJillian G Baker, Dominick E Shaw
British Journal of Pharmacology|April 25, 2003
The ups and downs of Gs- to Gi-protein switchingStephen J Hill, Jillian G Baker
The Journal of Pharmacology and Experimental Therapeutics|October 5, 2006
A comparison of the antagonist affinities for the Gi- and Gs-coupled states of the human adenosine A1-receptorJillian G Baker, Stephen J Hill
Handbook of Experimental Pharmacology|June 26, 2024
Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and AssaysJillian G Baker, Roger J Summers
Pharmacology Research & Perspectives|September 1, 2025
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β<sub>2</sub>-Agonists Used for Asthma and COPDRichard G W Proudman, Jillian G Baker
Pharmacology Research & Perspectives|August 6, 2021
The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptorsRichard G W Proudman, Jillian G Baker
European Journal of Cancer (Oxford, England : 1990)|June 8, 2021
Response to the letter Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patientsEdoardo Botteri, Jillian G Baker, Erica K Sloan
Trends in Pharmacological Sciences|March 25, 2011
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signallingJillian G Baker, Stephen J Hill, Roger J Summers
Pharmacology Research & Perspectives|September 14, 2022
The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptorsRichard G W Proudman, Juliana Akinaga, Jillian G Baker
Molecular Pharmacology|December 3, 2003
Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signalingJillian G Baker, Ian P Hall, Stephen J Hill
Pageof 6